Determining the effect of Tamsulosin on treatment of urinary obstruction symptoms in women
Design
Clinical trial with only intervention group, without blinding, phase 2 on 110 patients, data are entered into spss20 software after collection. Quantitative variables will be presented as mean and standard deviation, and qualitative variables will be presented as frequency.
Settings and conduct
Patients with obstructive symptoms Referred to Vaesi Hospital in Sabzevar and Private Urology Practice in Sabzevar are included in the study. First, the IPSS symptoms questionnaire is completed for patients. Then patients are subjected to uroflowmetry and determination of residual disease. Then Tamsulosin drug is taken at a dose of 0.4 mg once a day before going to bed for 1 month. The data before and after the intervention are statistically analyzed and compared since all the participants were treated with the same drug and the same dosage (0.4 ml g once a day) and there is no need to blind the samples.
Participants/Inclusion and exclusion criteria
Women up to 18 YO with urinary tract obstruction symptoms that did not find a reason for the obstruction symptoms in the investigations and the obstruction symptoms did not develop acutely.
Intervention groups
Patients with obstructive symptoms are included in the study. First, the IPSS symptoms questionnaire is completed for patients. Then all patients are subjected to uroflowmetry and determination of residual disease. Then Tamsulosin drug is taken for all patients at a dose of 0.4 mg once a day before going to bed for 1 month.